Is a complete OKUR research report available?

No complete published report is available for OnKure Therapeutics, Inc. (OKUR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

OnKure Therapeutics, Inc. (OKUR)

NASDAQ: OKUR · USD

$4.00

+0.05 (+1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first OKUR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	161.6M
Net income (ttm)	-58.7M
EPS (ttm)	-$4.33
Shares out	40.4M
Volume	62,396
Price target	$19.5	+387.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -58.7M
EPS (ttm): -$4.33
Market cap: 161.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All OKUR indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001637715
Company name	OnKure Therapeutics, Inc.
Country	United States
Country code	US
Cusip	68277Q105
Employees	45
Enterprise value	$-30.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US68277Q1058
Last refreshed	2026-07-31
Market cap	$161.6M
Market cap category	Micro-Cap
Price	$4
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	OKUR
Website	https://onkuretherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-36.54%
FCF yield	-31.59%
P/B ratio	0.87x
PS Forward	257.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-58.7M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profit Per Employee	$-1.3M
ROA	-25.77
ROCE	-33.39
ROE	-42.73
ROIC	-27.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	77.06%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$198.7M
Cash	$192.1M
Current Assets	$197.5M
Current Liabilities	$14.3M
Debt	$409,000
Debt Equity	$0
Equity	$184.4M
Interest Coverage	-7,695.6
Liabilities	$14.3M
Long Term Assets	$1.2M
Long Term Liabilities	$12,000
Net Cash	$191.7M
Net Cash By Market Cap	$119
Net Cash Growth	100.3%
Net Debt Equity	$-1.04
Tangible Book Value	$184.4M
Tangible Book Value Per Share	$4.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.78
Net Working Capital	$-8.5M
Quick ratio	13.41
Working Capital	$183.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-101.92%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	76.99%
200-day SMA	3.56
50-day SMA	4.22
50-day SMA vs 200-day SMA	50over200
All Time High	20
All Time High Change	-80%
All Time High Date	2024-10-07
All Time Low	1.7
All Time Low Change	135.29%
All Time Low Date	2025-05-13
ATR	0.32
Beta1y	0.84
Beta2y	1.24
Ch YTD	37.93
High	4.09
High52	5.38
High52 Date	2026-05-01
High52ch	-25.65%
Low	3.88
Low52	1.91
Low52 Date	2025-08-11
Low52ch	109.42%
Ma50ch	-5.24%
Price vs 200-day SMA	12.42%
RSI	42
RSI Monthly	22.43
RSI Weekly	51.48
Sharpe ratio	1.08x
Sortino ratio	1.9
Total Return	-101.92%
Tr YTD	37.93
Tr1m	-11.11%
Tr1w	-5.21%
Tr3m	-21.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	4
Analyst Price Target Top	$22.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.62
Earnings Revenue Estimate	200,000x
Operating Income	$-61.6M
Price target	$19.5
Price Target Change	$388
Price Target Change Top	$458

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,596,641%
Float Percent	43.56%
Shares Insiders	10.31%
Shares Institutions	30.84%
Shares Out	40,395,480
Shares Qo Q	0.57%
Shares Yo Y	101.92%
Short Float	6.71%
Short Ratio	2.51
Short Shares	2.93

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-62.5M
Adjusted OCF	-62,429,000
Average Volume	147,115.45x
Bv Per Share	4.56
CAPEX	$-33,000
Ch1m	-11.11
Ch1w	-5.21
Ch1y	76.99
Ch3m	-21.57
Ch6m	46.52
Change	1.27%
Change From Open	1.91
Close	3.95
Days Gap	-0.63
Depreciation Amortization	433,000
Dollar Volume	249,584
Earnings Date	2026-08-12
Earnings Time	bmo
EBIT	$-61.6M
EBITDA	$-61.1M
EPS	$-4.33
F Score	2
FCF	$-50.8M
FCF EV Yield	164.26x
FCF Per Share	$-1.26
Financing CF	146,239,000
Fiscal Year End	December
Founded	2,011
Investing CF	-33,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	3.74
Ma150ch	7.1%
Ma20	4.23
Ma20ch	-5.35%
Net CF	95,445,000
Next Earnings Date	2026-08-11
Open	3.93
Optionable	No
Position In Range	57.14
Ppne	807,000
Price Date	2026-07-30
Ptbv Ratio	0.87
Relative Volume	0.42x
Share Based Comp	11,668,000
Tr6m	46.52%
Us State	Colorado
Volume	62,396

OnKure Therapeutics, Inc. (OKUR)

Coverage state: Market snapshot only — no published research

Generate the first OKUR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · OKUR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OKUR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on OKUR

Frequently asked questions